MENU
NBY
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

NovaBay Pharmaceuticals (NBY) Ownership - Who owns NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
6.49M
P/E Ratio
0.21
Total Cash
N/A
Projected Growth
N/A
Total Debt
1.04M
Revenue
9.78M
Risk (Beta)
0.72
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
1.47 USD as % of share price

Fundamentals

NBY
Capitalization
6.49M
P/E Ratio
0.21
Risk (Beta)
0.72
Dividend Yield
N/A
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
1.04M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.47%
Revenue
9.78M
ROE
N/A
Book Value
4.24M
P/B Ratio
1.52
Cash Flow
N/A
Earnings
4.07
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
58K
Current Ratio
2.85
Current Revenue Per Employee
164928.58
Dividends Per Share - Security
N/A
EBITDA
-7.05M
Float
N/A
Float - Current
N/A
Gross Income Margin
65.05
Revenue To Assets
42.80
Shares Held By Institutions
167K
Shares Outstanding - Current
6.01M
Total Liabilities
2.67M
Total Volume MTD
N/A
Value
1
Gain YTD
171.855
View a ticker or compare two or three
NBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2000 Powell Street
Phone
+1 510 899-8800
Employees
26
Web
https://www.novabay.com